These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7396272)

  • 1. [Persistance of fetal circulation. a case associated to maternal indomethacin administration (author's transl)].
    Molina V; Krauel J; Baraibar R; Campistol J
    An Esp Pediatr; 1980 Feb; 13(2):162-8. PubMed ID: 7396272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostaglandin and threat of premature labour inhibitors. 1. The possibilities and consequences (as given in the literature) (author's transl)].
    Maria B
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(6):721-5. PubMed ID: 7462576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn.
    Turner GR; Levin DL
    Clin Perinatol; 1984 Oct; 11(3):581-9. PubMed ID: 6488671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maternal treatment with indomethacin and severe neonatal pulmonary hypertension (author's transl)].
    Dalens B; Dechelotte P; Gaulme J; Raynaud EJ
    Arch Fr Pediatr; 1981 Apr; 38(4):261-5. PubMed ID: 7294953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The persistent pulmonary hypertension syndrome in neonates after intrauterine exposure to indomethacin].
    Slavík Z; Zborilová B; Hruda J
    Cesk Pediatr; 1990 Jun; 45(6):357-8. PubMed ID: 2289257
    [No Abstract]   [Full Text] [Related]  

  • 6. [Twin pregnancy, indomethacin and neonatal cyanosis (author's transl)].
    Boulley AM; Dehan M; Vial M; Hernandorena X; Ropert JC; Laudignon N; Lhermitte C; Gabilan JC
    Arch Fr Pediatr; 1980 May; 37(5):317-9. PubMed ID: 7469707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of indomethacin on fetal rat lungs: a possible cause of persistent fetal circulation (PFC).
    Harker LC; Kirkpatrick SE; Friedman WF; Bloor CM
    Pediatr Res; 1981 Feb; 15(2):147-51. PubMed ID: 7196010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of inhibitors of prostaglandin synthesis in the perinatal period.
    Berman W; Friedman Z; Vidyasagar D
    Semin Perinatol; 1980 Jan; 4(1):67-72. PubMed ID: 6770469
    [No Abstract]   [Full Text] [Related]  

  • 9. [Maternal administration of indomethacin and neonatal tricuspid insufficiency].
    Magny JF; Petit J; Saby MA; Dehan M; Gabilan JC
    Arch Fr Pediatr; 1987 Mar; 44(3):189-90. PubMed ID: 3579483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients].
    Marpeau L; Keskes J; Vincenti O; Boyer F; Bouillie J; Pigné A; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(1):115-22. PubMed ID: 3280651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The persistence of foetal circulation. Neonatal pulmonary arterial hypertension. Favourable action of tolazoline (author's transl)].
    Monin P; Vert P
    Nouv Presse Med; 1978 Sep; 7(32):2853-4, 2859-61. PubMed ID: 714666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for persistent pulmonary hypertension of the newborn.
    Hernández-Díaz S; Van Marter LJ; Werler MM; Louik C; Mitchell AA
    Pediatrics; 2007 Aug; 120(2):e272-82. PubMed ID: 17671038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Persistent pulmonary hypertension in the newborn caused by prenatal use of prostaglandin inhibitors, (indomethacin). Report of a case].
    Lozano González CH; Galindo Jiménez P; Pezzotti MA; Lowenberg Favela E
    Ginecol Obstet Mex; 1980 Aug; 48(286):103-10. PubMed ID: 7450523
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure.
    Tarcan A; Gürakan B; Yildirim S; Ozkiraz S; Bilezikçi B
    J Perinat Med; 2004; 32(1):98-9. PubMed ID: 15008397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn.
    Manchester D; Margolis HS; Sheldon RE
    Am J Obstet Gynecol; 1976 Oct; 126(4):467-9. PubMed ID: 985646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of an inhibitor of prostaglandins biosynthesis (indomethacin) on the rat implantation (author's transl)].
    Abad Gavín M; Domínguez Fernández-Tejerina JC; Montañes de las Heras MF; Vijil Maeso E
    Reproduccion; 1974; 1(2):177-83. PubMed ID: 4480302
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for persistent ductus arteriosus patency during indomethacin treatment.
    Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI
    J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preterm delivery after indomethacin. A risk factor for neonatal complications?
    Gardner MO; Owen J; Skelly S; Hauth JC
    J Reprod Med; 1996 Dec; 41(12):903-6. PubMed ID: 8979204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacological manipulation of Botallo's duct in the duct-dependent congenital cardiopathies and in the preterm infants with respiratory distress. A review and personal findings].
    Distefano G
    Minerva Pediatr; 2005 Feb; 57(1):21-34. PubMed ID: 15791199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibition of prostaglandin synthesis on fetal development, oxygenation, and the fetal circulation.
    Levin DL
    Semin Perinatol; 1980 Jan; 4(1):35-44. PubMed ID: 6992279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.